CN1919873B - 包含人HSP70 ATPase结构域与哺乳动物p53蛋白的融合蛋白及其应用 - Google Patents
包含人HSP70 ATPase结构域与哺乳动物p53蛋白的融合蛋白及其应用 Download PDFInfo
- Publication number
- CN1919873B CN1919873B CN200510137774XA CN200510137774A CN1919873B CN 1919873 B CN1919873 B CN 1919873B CN 200510137774X A CN200510137774X A CN 200510137774XA CN 200510137774 A CN200510137774 A CN 200510137774A CN 1919873 B CN1919873 B CN 1919873B
- Authority
- CN
- China
- Prior art keywords
- cell
- mouse
- tumour
- albumen
- fusion rotein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (7)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200510137774XA CN1919873B (zh) | 2005-08-25 | 2005-08-25 | 包含人HSP70 ATPase结构域与哺乳动物p53蛋白的融合蛋白及其应用 |
HK07105195.5A HK1098765A1 (en) | 2005-08-25 | 2007-05-16 | Fusion protein containing human hsp70 atpase domain and mammalian p53 protein and the use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200510137774XA CN1919873B (zh) | 2005-08-25 | 2005-08-25 | 包含人HSP70 ATPase结构域与哺乳动物p53蛋白的融合蛋白及其应用 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200510096588 Division CN1919872A (zh) | 2005-08-25 | 2005-08-25 | 包含人HSP70 ATPase结构域与抗原肽的融合蛋白及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1919873A CN1919873A (zh) | 2007-02-28 |
CN1919873B true CN1919873B (zh) | 2012-05-30 |
Family
ID=37777746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200510137774XA Active CN1919873B (zh) | 2005-08-25 | 2005-08-25 | 包含人HSP70 ATPase结构域与哺乳动物p53蛋白的融合蛋白及其应用 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN1919873B (zh) |
HK (1) | HK1098765A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101117635B (zh) * | 2006-07-31 | 2013-07-31 | 中国人民解放军军事医学科学院毒物药物研究所 | Ptd、hif的odd与肿瘤抑制基因的融合表达及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1411512A (zh) * | 1999-10-20 | 2003-04-16 | 约翰霍普金斯大学医学院 | 嵌合的免疫原性组合物及其编码核酸 |
WO2004058801A2 (en) * | 2002-12-23 | 2004-07-15 | City Of Hope | Modified vaccinia ankara expressing p53 in cancer immunotherapy |
-
2005
- 2005-08-25 CN CN200510137774XA patent/CN1919873B/zh active Active
-
2007
- 2007-05-16 HK HK07105195.5A patent/HK1098765A1/xx unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1411512A (zh) * | 1999-10-20 | 2003-04-16 | 约翰霍普金斯大学医学院 | 嵌合的免疫原性组合物及其编码核酸 |
WO2004058801A2 (en) * | 2002-12-23 | 2004-07-15 | City Of Hope | Modified vaccinia ankara expressing p53 in cancer immunotherapy |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101117635B (zh) * | 2006-07-31 | 2013-07-31 | 中国人民解放军军事医学科学院毒物药物研究所 | Ptd、hif的odd与肿瘤抑制基因的融合表达及其应用 |
Also Published As
Publication number | Publication date |
---|---|
HK1098765A1 (en) | 2007-07-27 |
CN1919873A (zh) | 2007-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bolhassani et al. | Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies | |
EP1002110B2 (en) | Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins | |
AU2007308576B2 (en) | HPV antigen fusion protein vaccine compositions and uses thereof | |
Tindle et al. | A vaccine conjugate of ‘ISCAR’immunocarrier and peptide epitopes of the E7 cervical cancer‐associated protein of human papillomavirus type 16 elicits specific Th1‐and Th2‐type responses in immunized mice in the absence of oil‐based adjuvants | |
Shahbazi et al. | Comparison of six cell penetrating peptides with different properties for in vitro and in vivo delivery of HPV16 E7 antigen in therapeutic vaccines | |
CN106632694B (zh) | 一种重组蛋白及药物组合物与应用 | |
EP1644048B1 (en) | Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein | |
Bolhassani et al. | Mini-chaperones: potential immuno-stimulators in vaccine design | |
EP1468012A1 (en) | Biomolecule transduction motif mph-1-btm and the use thereof | |
CN105175527A (zh) | 一种乳腺癌特异性的热休克蛋白复合物及其应用 | |
CN101808658A (zh) | 细胞穿透肽及其与具有治疗作用的生物分子相融合的用途 | |
CN113769080A (zh) | 多肽免疫偶联物及其应用 | |
Torréns et al. | Immunotherapy with CTL peptide and VSSP eradicated established human papillomavirus (HPV) type 16 E7-expressing tumors | |
CN101036784B (zh) | 一种乙型肝炎治疗性细胞毒性t细胞表位疫苗及其制备方法 | |
JP4474264B2 (ja) | 子宮頸癌抑制の融合蛋白 | |
CN103864938A (zh) | 靶特异性双突变体融合蛋白质及其制备工艺 | |
CN101698852B (zh) | 具有cd137l功能的蛋白或多肽及其基因和应用 | |
Lu et al. | Cytotoxic T cell responses are enhanced by antigen design involving the presentation of MUC1 peptide on cholera toxin B subunit | |
CN1919873B (zh) | 包含人HSP70 ATPase结构域与哺乳动物p53蛋白的融合蛋白及其应用 | |
CN116970058A (zh) | 针对tp53基因r249s突变的肿瘤新抗原多肽及其应用 | |
EP1468011A1 (en) | Biomolecule transduction motif sim-2-btm and the use thereof | |
Bolhassani et al. | The efficiency of a novel delivery system (PEI600-Tat) in development of potent DNA vaccine using HPV16 E7 as a model antigen | |
CN104211772A (zh) | 结直肠癌抗原肽与热休克蛋白的复合物及其应用 | |
WO2002036611A2 (en) | Immunomodulatory peptides derived from heat shock proteins and uses thereof | |
WO2022111475A1 (zh) | 一种识别hpv抗原的tcr |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1098765 Country of ref document: HK |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SHADONG BIOLOGICAL TECHNOLOGY CO., LTD., BEIJING Free format text: FORMER OWNER: SHADONG BIOLOGICAL PHARMACY (TIANJIN) CO., LTD. Effective date: 20100910 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 300457 8/F, TOWER A1, TIANDA SCIENCE + TECHNOLOGY PARK, NO.80, FOURTH AVENUE, ECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE, TIANJIN CITY, CHINA TO: 100176 BUILDING 15, JIAJIE SCIENCE + TECHNOLOGY PARK, YARD 26, WEST RING SOUTH ROAD, ECONOMIC AND TECHNOLOGICAL AREA BEIJING CITY DEVELOPMENT ZONE, CHINA |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20100910 Address after: 100176 China Beijing economic and Technological Development Zone (Yizhuang) science and Technology Park West Jiajie Road No. 26 Building No. 15 hospital Applicant after: Shadong Biological Technology Co., Ltd., Beijing Address before: 300457, Tianjin economic and Technological Development Zone Fourth Avenue 80, Tian Da Science and Technology Park, block A1, 8 Applicant before: Shadong biological pharmaceutical (Tianjin) Co. Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1098765 Country of ref document: HK |